Johnson Financial Group Inc. increased its position in shares of Monsanto Company (NYSE:MON) by 5,636.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,203 shares of the basic materials company’s stock after buying an additional 8,060 shares during the period. Johnson Financial Group Inc.’s holdings in Monsanto were worth $971,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Swiss National Bank increased its stake in shares of Monsanto by 25.6% during the first quarter. Swiss National Bank now owns 1,676,066 shares of the basic materials company’s stock worth $189,731,000 after buying an additional 341,400 shares during the period. United Services Automobile Association increased its stake in shares of Monsanto by 5.6% during the first quarter. United Services Automobile Association now owns 265,378 shares of the basic materials company’s stock worth $30,041,000 after buying an additional 14,076 shares during the period. Nikko Asset Management Americas Inc. increased its stake in shares of Monsanto by 1.3% during the second quarter. Nikko Asset Management Americas Inc. now owns 450,700 shares of the basic materials company’s stock worth $53,345,000 after buying an additional 5,700 shares during the period. WFG Advisors LP increased its stake in shares of Monsanto by 19.4% during the first quarter. WFG Advisors LP now owns 2,377 shares of the basic materials company’s stock worth $269,000 after buying an additional 387 shares during the period. Finally, Bank of The Ozarks increased its stake in shares of Monsanto by 14.2% during the first quarter. Bank of The Ozarks now owns 9,150 shares of the basic materials company’s stock worth $1,035,000 after buying an additional 1,135 shares during the period. Hedge funds and other institutional investors own 74.79% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Johnson Financial Group Inc. Purchases 8,060 Shares of Monsanto Company (MON)” was originally posted by Equities Focus and is the sole property of of Equities Focus. If you are accessing this article on another website, it was copied illegally and republished in violation of US and international copyright and trademark laws. The legal version of this article can be viewed at https://www.equitiesfocus.com/2017/09/17/johnson-financial-group-inc-purchases-8060-shares-of-monsanto-company-mon.html.
Shares of Monsanto Company (MON) opened at 118.27 on Friday. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $118.97. The stock has a 50 day moving average price of $117.25 and a 200 day moving average price of $116.44. The firm has a market capitalization of $51.96 billion, a P/E ratio of 25.54 and a beta of 1.07.
Monsanto (NYSE:MON) last issued its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. The company had revenue of $4.23 billion during the quarter, compared to analyst estimates of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The business’s revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the firm earned $2.17 EPS. Equities analysts anticipate that Monsanto Company will post $4.89 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be given a $0.54 dividend. The ex-dividend date is Thursday, October 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.83%. Monsanto’s payout ratio is 46.75%.
In other news, EVP Robert T. Fraley sold 52,410 shares of Monsanto stock in a transaction that occurred on Monday, July 10th. The stock was sold at an average price of $117.95, for a total value of $6,181,759.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Steven Mizell sold 11,300 shares of Monsanto stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total value of $1,339,841.00. Following the completion of the transaction, the executive vice president now owns 55,011 shares of the company’s stock, valued at approximately $6,522,654.27. The disclosure for this sale can be found here. 0.79% of the stock is currently owned by company insiders.
A number of research firms recently weighed in on MON. BidaskClub upgraded shares of Monsanto from a “sell” rating to a “hold” rating in a research note on Thursday, June 29th. Barclays PLC upped their target price on shares of Monsanto from $115.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Thursday, June 29th. Royal Bank Of Canada restated a “sector perform” rating and set a $128.00 target price (up from $120.00) on shares of Monsanto in a research note on Thursday, June 29th. Zacks Investment Research lowered shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Tuesday, July 4th. Finally, Jefferies Group LLC restated a “hold” rating and set a $128.00 target price on shares of Monsanto in a research note on Friday. Ten equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $124.09.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.